Terms: = Breast cancer AND TGFBR2, AAT3, 7048, ENSG00000163513, P37173, TGFbeta-RII, RIIC, TAAD2, FAA3, TGFR-2, MFS2, HNPCC6 AND Treatment
12 results:
1. Effect of aza-BODIPY-photodynamic therapy on the expression of carcinoma-associated genes and cell death mode.
Elgun T; Yurttas AG; Cinar K; Ozcelik S; Gul A
Photodiagnosis Photodyn Ther; 2023 Dec; 44():103849. PubMed ID: 37863378
[TBL] [Abstract] [Full Text] [Related]
2. Single nucleotide polymorphisms associated with female breast cancer susceptibility in Chinese population.
Jia Z; Huang Y; Liu J; Liu G; Li J; Xu H; Jiang Y; Zhang S; Wang Y; Chen G; Qiao G; Li Y
Gene; 2023 Oct; 884():147676. PubMed ID: 37524136
[TBL] [Abstract] [Full Text] [Related]
3. Redistribution of the SWI/SNF Complex Dictates Coordinated Transcriptional Control over Epithelial-Mesenchymal Transition of Normal breast Cells through TGF-β Signaling.
Jdeed S; Lengyel M; Uray IP
Cells; 2022 Aug; 11(17):. PubMed ID: 36078038
[TBL] [Abstract] [Full Text] [Related]
4. ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer.
Sun X; He Z; Guo L; Wang C; Lin C; Ye L; Wang X; Li Y; Yang M; Liu S; Hua X; Wen W; Lin C; Long Z; Zhang W; Li H; Jian Y; Zhu Z; Wu X; Lin H
J Exp Clin Cancer Res; 2021 Apr; 40(1):149. PubMed ID: 33931075
[TBL] [Abstract] [Full Text] [Related]
5. Coexpression Module Construction by Weighted Gene Coexpression Network Analysis and Identify Potential Prognostic Markers of breast cancer.
Wang Y; Cui K; Zhu M; Gu Y
Cancer Biother Radiopharm; 2022 Oct; 37(8):612-623. PubMed ID: 33052716
[No Abstract] [Full Text] [Related]
6. Identification and characterization of biomarkers and their functions for Lapatinib-resistant breast cancer.
Zhang L; Huang Y; Zhuo W; Zhu Y; Zhu B; Chen Z
Med Oncol; 2017 May; 34(5):89. PubMed ID: 28393315
[TBL] [Abstract] [Full Text] [Related]
7. Endovascular treatment of a dural arteriovenous fistula in a patient with Loeys-Dietz syndrome: A case report.
Aoki R; Srivatanakul K; Osada T; Hotta K; Sorimachi T; Matsumae M; Morisaki H
Interv Neuroradiol; 2017 Apr; 23(2):206-210. PubMed ID: 28304197
[TBL] [Abstract] [Full Text] [Related]
8. Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance.
Busch S; Sims AH; Stål O; Fernö M; Landberg G
Cancer Res; 2015 Apr; 75(7):1457-69. PubMed ID: 25833830
[TBL] [Abstract] [Full Text] [Related]
9. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.
Busch S; Acar A; Magnusson Y; Gregersson P; Rydén L; Landberg G
Oncogene; 2015 Jan; 34(1):27-38. PubMed ID: 24336330
[TBL] [Abstract] [Full Text] [Related]
10. Inflammation-mediated genetic and epigenetic alterations drive cancer development in the neighboring epithelium upon stromal abrogation of TGF-β signaling.
Achyut BR; Bader DA; Robles AI; Wangsa D; Harris CC; Ried T; Yang L
PLoS Genet; 2013; 9(2):e1003251. PubMed ID: 23408900
[TBL] [Abstract] [Full Text] [Related]
11. TGF-β receptor II loss promotes mammary carcinoma progression by Th17 dependent mechanisms.
Novitskiy SV; Pickup MW; Gorska AE; Owens P; Chytil A; Aakre M; Wu H; Shyr Y; Moses HL
Cancer Discov; 2011 Oct; 1(5):430-41. PubMed ID: 22408746
[TBL] [Abstract] [Full Text] [Related]
12. Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?
Tan AR; Alexe G; Reiss M
Breast Cancer Res Treat; 2009 Jun; 115(3):453-95. PubMed ID: 18841463
[TBL] [Abstract] [Full Text] [Related]
